The findings of significant interactions between genes from the RA, bradykinin, and fibrinolytic systems on the risk of cardiovascular disease warrant further exploration, including attempting to replicate these results in other populations with other study designs. This evidence concerns the gene KNG1 and cardiovascular disorder.